Christine Mayr - Publications

Affiliations: 
Memorial Sloan-Kettering Cancer Center, Rockville Centre, NY, United States 
Area:
mRNA metabolism in cancer
Website:
http://www.mskcc.org/research/lab/christine-mayr

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Mayr C. Evolution and Biological Roles of Alternative 3'UTRs. Trends in Cell Biology. PMID 26597575 DOI: 10.1016/J.Tcb.2015.10.012  1
2015 Berkovits BD, Mayr C. Alternative 3' UTRs act as scaffolds to regulate membrane protein localization. Nature. 522: 363-7. PMID 25896326 DOI: 10.1038/Nature14321  1
2015 Mayr C. Cell scientist to watch - Christine Mayr Journal of Cell Science. 128: 4251-4252. DOI: 10.1242/jcs.181958  1
2013 Lianoglou S, Garg V, Yang JL, Leslie CS, Mayr C. Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expression. Genes & Development. 27: 2380-96. PMID 24145798 DOI: 10.1101/Gad.229328.113  1
2009 Mayr C, Bartel DP. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell. 138: 673-84. PMID 19703394 DOI: 10.1016/J.Cell.2009.06.016  1
2009 Pallasch CP, Patz M, Park YJ, Hagist S, Eggle D, Claus R, Debey-Pascher S, Schulz A, Frenzel LP, Claasen J, Kutsch N, Krause G, Mayr C, Rosenwald A, Plass C, et al. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood. 114: 3255-64. PMID 19692702 DOI: 10.1182/Blood-2009-06-229898  1
2008 Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB. Alternative isoform regulation in human tissue transcriptomes. Nature. 456: 470-6. PMID 18978772 DOI: 10.1038/Nature07509  1
2008 Wiesner M, Zentz C, Mayr C, Wimmer R, Hammerschmidt W, Zeidler R, Moosmann A. Conditional immortalization of human B cells by CD40 ligation. Plos One. 3: e1464. PMID 18213373 DOI: 10.1371/Journal.Pone.0001464  1
2008 Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely (Proceedings of the National Academy of Sciences of the United States of America (2007) 104, 17, (7080-7085) DOI: 10.1073/pnas.0702409104) Proceedings of the National Academy of Sciences of the United States of America. 105: 18071. DOI: 10.1073/pnas.0809324105  1
2007 Bund D, Mayr C, Kofler DM, Hallek M, Wendtner CM. CD23 is recognized as tumor-associated antigen (TAA) in B-CLL by CD8+ autologous T lymphocytes. Experimental Hematology. 35: 920-30. PMID 17533046 DOI: 10.1016/J.Exphem.2007.03.001  1
2007 Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proceedings of the National Academy of Sciences of the United States of America. 104: 7080-5. PMID 17438277 DOI: 10.1073/Pnas.0702409104  1
2007 Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science (New York, N.Y.). 315: 1576-9. PMID 17322030 DOI: 10.1126/Science.1137999  1
2006 Kofler DM, Mayr C, Wendtner CM. Current status of immunotherapy in B cell malignancies. Current Drug Targets. 7: 1371-4. PMID 17073599 DOI: 10.2174/138945006778559120  1
2006 Bund D, Mayr C, Kofler DM, Hallek M, Wendtner CM. Human Ly9 (CD229) as novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (B-CLL) recognized by autologous CD8+ T cells. Experimental Hematology. 34: 860-9. PMID 16797413 DOI: 10.1016/J.Exphem.2006.04.010  1
2006 Mayr C, Bund D, Schlee M, Bamberger M, Kofler DM, Hallek M, Wendtner CM. MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes. Experimental Hematology. 34: 44-53. PMID 16413390 DOI: 10.1016/J.Exphem.2005.09.016  1
2006 Mayr C, Speicher MR, Kofler DM, Buhmann R, Strehl J, Busch R, Hallek M, Wendtner CM. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood. 107: 742-51. PMID 16179374 DOI: 10.1182/Blood-2005-05-2093  1
2005 Mayr C, Kofler DM, Büning H, Bund D, Hallek M, Wendtner CM. Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells. Blood. 106: 3223-6. PMID 16014560 DOI: 10.1182/Blood-2005-04-1742  1
2005 Mayr C, Bund D, Schlee M, Moosmann A, Kofler DM, Hallek M, Wendtner CM. Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. Blood. 105: 1566-73. PMID 15471955 DOI: 10.1182/Blood-2004-04-1233  1
2004 Wendtner CM, Kofler DM, Mayr C, Bund D, Hallek M. The potential of gene transfer into primary B-CLL cells using recombinant virus vectors. Leukemia & Lymphoma. 45: 897-904. PMID 15291346 DOI: 10.1080/10428190310001638896  1
2004 Kofler DM, Büning H, Mayr C, Bund D, Baumert J, Hallek M, Wendtner CM. Engagement of the B-cell antigen receptor (BCR) allows efficient transduction of ZAP-70-positive primary B-CLL cells by recombinant adeno-associated virus (rAAV) vectors. Gene Therapy. 11: 1416-24. PMID 15269708 DOI: 10.1038/sj.gt.3302279  1
2003 Strehl J, Mey U, Glasmacher A, Djulbegovic B, Mayr C, Gorschlüter M, Ziske C, Schmidt-Wolf IG. High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma: a meta-analysis. Haematologica. 88: 1304-15. PMID 14607760 DOI: 10.3324/%%X  1
2000 Hildebrandt M, Rose M, Mayr C, Arck P, Schüler C, Reutter W, Salama A, Klapp BF. Dipeptidyl peptidase IV (DPP IV, CD26) in patients with mental eating disorders. Advances in Experimental Medicine and Biology. 477: 197-204. PMID 10849747 DOI: 10.1007/0-306-46826-3_22  0.72
1999 Hildebrandt M, Rose M, Mayr C, Schüler C, Reutter W, Salama A, Klapp BF. Alterations in expression and in serum activity of dipeptidyl peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders. Scandinavian Journal of Immunology. 50: 536-41. PMID 10564557 DOI: 10.1046/j.1365-3083.1999.00612.x  0.72
Show low-probability matches.